| Gaps
in Data
The
following gaps in data regarding
medicinal plants have been identified:
Surveys
Thorough surveys of all presently
known and potential medicinal plants
of Northern Areas needs to be carried
out. There are more such plants
in this area than are currently
well known and they need to be identified
and catalogued.
Status
The status of many medicinal plants
is not known. Surveys need to be
done to establish the status and
if they are threatened, then the
level of threat needs to be determined,
i.e., whether they are endangered,
vulnerable etc.
Cost
analysis and marketing
Detailed cost analysis of all the
procedures related to major medicinal
plants needs to be done along the
lines of the one conducted by WWF-Pakistan.
Analysis should involve aspects
such as plant/berry picking, product
preparation and marketing. This
would help determine a fair price
for the farmer who at present generally
sells the plant at any price that
the middlemen are willing to offer
or expects a higher price than he
can get realistically.
Intellectual
property rights
The area of patenting and intellectual
property rights of medicinal plant
products needs greater attention.
As more plants are recognized and
bought by companies, this issue
will become more important. The
situation presently is that the
knowledge of local people which
is crucial to drug development generally
go unrewarded. But times are changing
and the matter of financial compensation
for indigenous botanical knowledge
has gained attention. In the Northern
Areas too, therefore, this matter
needs closer scrutiny.
Status
of traditional knowledge
Although there is anecdotal evidence
and a general feeling that traditional
ethnobotanical knowledge is being
lost steadily due to greater acceptance
of allopathic medicine, there is
no systematic survey to determine
this. Studies should be conducted
to establish how much of such knowledge
is being retained or lost by successive
generations because that would help
in preserving such knowledge in
the long run.
|